Advancing Animal Health Through Innovative Biologics
Animals play an essential role in our lives, whether as companions or as vital sources of food and resources. At 3PBIOVIAN, we harness our expertise in recombinant protein biologics and advanced therapies to successfully develop and manufacture next-generation solutions for animal health. As a long-term strategic partner for animal health innovators, we help transform cutting edge research into commercially viable therapies that improve the lives of animals worldwide.
Proven CDMO Experience in Veterinary Vaccines and Biological Therapies
3PBIOVIAN has a proven track record in the development and manufacturing of animal health vaccines. We support veterinary vaccine programs at every stage, from cell line and process development through scale-up and commercial manufacturing.
We routinely manufacture GMP batches for commercial veterinary products, ensuring consistent quality, reliable supply, and regulatory compliance.
Dedicated CDMO Services for Veterinary Biologics
We understand the technical, regulatory, and commercial complexities of veterinary products and offer tailored services to meet our clients’ specific needs.
Whether you are developing, novel vaccines, recombinant proteins, or monoclonal antibodies, we provide the speed, quality, robustness, and scalability that are essential to efficiently advance from preclinical development to GMP production and routine commercial manufacturing.
Your Strategic Manufacturing Partner for Animal Health
We collaborate with a diverse range of animal health organizations, including:
- Startups developing innovative vaccine and biologic platforms
- Established biotech firms advancing antibody-based therapies for companion and production animals
- Global pharmaceutical companies outsourcing their animal health portfolios requiring microbial and mammalian manufacturing
- Academic and veterinary institutions requiring non-GMP and GMP material for pre-clinical and clinical programs
Our role extends beyond development— we are a long-term partner committed to delivering sustained value as the program progresses to dependable commercial supply.
GMP Biologics Manufacturing for Animal Health
Our development and manufacturing capabilities span multiple biologic modalities and platforms, including:
- Recombinant protein and antibodies expressed in microbial and mammalian systems
- Plasmid DNA
- Viral vectors (adenovirus and AAV)
- Advanced biologic and cell-based therapies
With a wide range of bioreactor scales and flexible manufacturing configurations, we ensure a smooth transition from development stages to clinical and commercial production.
Manufacturing
Capacity
Mammalian (single-use bioreactors): 50 L | 200 L | 400 L | 2,000 L
Microbial (stainless-steel bioreactors): 10 L | 100 L | 200 L | 500 L | 1,000 L | 3,000 L
Viral vector manufacturing:
- Adherent systems: up to 500 m²
- Suspension systems: 10 L to 200 L
Plasmid DNA (stainless steel): 20 L | 40 L | 200 L
Why Animal Health Companies Partner with 3PBIOVIAN
Animal health companies choose 3PBIOVIAN because we offer:
- A demonstrated track record in animal health biopharmaceutical development and commercial manufacturing
- Seamless transition from process development and tech transfer to scale-up and large-scale manufacturing
- Flexible infrastructure tailored to support commercial manufacturing needs
- A flexible and cost-conscious CDMO model designed to align with the animal health market
Whether you are launching a new veterinary therapeutic or vaccine or are seeking a dependable long-term manufacturing partner, 3PBIOVIAN offers comprehensive support for your program from development to sustained market supply.
3PBIOVIAN — your trusted partner in delivering veterinary vaccines and biologic therapies, from sequence to market.